MET Filing
4Filing Date: Jun 11, 2026
METLIFE INC (MET) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001714199-26-000007open_in_new
Total Value$10.9K
Trades1
Insiders1
Transaction Details
TADROS RAMY
President, U.S. Business·Direct
Grant · Acquire
Common Stock
Shares+127
Price$85.57
Total Value$10.9K
Shares Owned After216.95K
Transaction DateJun 9, 2026
Footnotes ▸
Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.
Post-Transaction Holdings
TADROS RAMY
| Security | Shares | Change |
|---|---|---|
| Common Stock | 216.95K | +127 (0.06%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-09
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: METLIFE INC (MET)
CIK: 0001099219
--- Reporting Owner ---
Name: TADROS RAMY
CIK: 0001714199
Role: Officer (President, U.S. Business)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-09 | Code: A (Grant or award)
Shares: +127 | Price: $85.57
Total Value: $10,867.39
Shares Owned After: 216,946 | Ownership: D (Direct)
Footnotes:
[F1] Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.
--- Footnotes (Complete Index) ---
F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.
--- Signature ---
/s/ /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact (2026-06-11)